Why is Advanced Enzyme falling/rising?

As of 18-Aug, Advanced Enzyme Technologies Ltd is experiencing a decline in its stock price, currently at 308.05, reflecting a decrease of 0.7 or 0.23%. The stock has underperformed its sector by 1.25% today and has seen a trend reversal after two consecutive days of gains. Over the past week, the stock has increased by 1.97%, but it has struggled in the longer term, with a 1-month return of -4.48% and a year-to-date decline of -11.22%. Despite having a low debt-to-equity ratio and strong operating cash flow, the stock's long-term growth appears poor, with an annual operating profit decline of -1.44% over the last five years. Additionally, while institutional holdings are high at 31.91%, indicating confidence from larger investors, the stock's return over the past year has been significantly negative at -27.69%, with profits also falling by -8.8%. In the broader market context, the stock's recent performance contrasts with the benchmark, as the Sensex has shown a positive return of 0.83% over the past week and a gain of 4.01% year-to-date. This underperformance highlights the challenges Advanced Enzyme faces in attracting investor confidence, particularly given its substantial decline compared to the market's relatively stable performance. The stock's valuation is considered expensive with a Price to Book Value of 2.4, further complicating its appeal in a market that has not favored it over the past year. Overall, the combination of poor long-term growth prospects and significant underperformance relative to the market contributes to the stock's current downward movement.